FDA NDC Directory · JSON-LD · Markdown

Bendamustine Hydrochloride

NDC 60505-6228 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerApotex Corp
Marketing categoryNew Drug Application (innovator) · App NDA215033
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsBENDAMUSTINE HYDROCHLORIDE (25 mg/mL)
Marketing started20230426
Package count1

External sources

Source: openFDA. Public-domain (CC0).